1 |
Hoffman JI, Kaplan S. The incidence of congenital heart disease [J]. J Am Coll Cardiol, 2002, 39 (12): 1890-1900.
|
2 |
Di Tullio MR. Patent foramen ovale: echocardiographic detection and clinical relevance in stroke [J]. J Am Soc Echocardiogr, 2010, 23(2): 144-220.
|
3 |
Lee PH, Song JK, Kim JS, et al. Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial [J]. J Am Coll Cardiol, 2018, 71(20): 2335-2342.
|
4 |
Miranda B, Fonseca AC, Ferro JM. Patent foramen ovale and stroke [J]. J Neurol, 2018, 265(8): 1943-1949.
|
5 |
Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke [J]. N Engl J Med, 2017, 377(11): 1022-1032.
|
6 |
Mojadidi MK, Ruiz JC, Chertoff J, et al. Patent foramen ovale and hypoxemia [J]. Cardiol Rev, 2019, 27(1): 34-40.
|
7 |
Agarwal S, Bajaj NS, Kumbhani DJ, et al. Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism [J]. JACC Cardiovasc Interv, 2012, 5(7): 777-789.
|
8 |
Belvís R, Leta RG, Martí-Fàbregas J, et al. Almost perfect concordance between simultaneous transcranial Doppler and transesophageal echocardiography in the quantification of right-to-left shunts [J]. J Neuroimaging, 2006, 16(2): 133-138.
|
9 |
Chen J, Chen L, Hu W, et al. A comparison of contrast transthoracic echocardiography and contrast transcranial Doppler in cryptogenic stroke patients with patent foramen ovale [J]. Brain Behav, 2019, 9(5): e01283.
|
10 |
Schuchlenz HW, Weihs W, Horner S, et al. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events [J]. Am J Med, 2000, 109(6): 456-462.
|
11 |
Freeman JA, Woods TD. Use of saline contrast echo timing to distinguish intracardiac and extracardiac shunts: failure of the 3- to 5-beat rule [J]. Echocardiography, 2008, 25(10): 1127-1130.
|
12 |
Mojadidi MK, Zaman MO, Elgendy IY, et al. Cryptogenic stroke and patent foramen ovale [J]. J Am Coll Cardiol, 2018, 71(9): 1035-1043.
|
13 |
Gonzalez JB, Testai FD. Advances and ongoing controversies in patent foramen ovale closure and cryptogenic stroke [J]. Neurol Clin, 2021, 39(1): 51-69.
|
14 |
Pristipino C, Sievert H, D'Ascenzo F, et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism [J]. Eur Heart J, 2019, 40(38): 3182-3195.
|
15 |
Lynch JJ, Schuchard GH, Gross CM, et al. Prevalence of right-to-left atrial shunting in a healthy population: detection by Valsalva maneuver contrast echocardiography [J]. Am J Cardiol, 1984, 53(10): 1478-1480.
|
16 |
罗晓惠, 杜亚娟, 张玉顺. 卵圆孔未闭患者标准化右心声学造影与传统方法的比较 [J]. 心脏杂志, 2018, 30(5): 571-574.
|
17 |
Zhao E, Zhang Y, Kang C, et al. Influence of the Valsalva maneuver on cardiac hemodynamics and right to left shunt in patients with patent foramen ovale [J]. Sci Rep, 2017, 7: 44280.
|
18 |
Rodrigues AC, Picard MH, Carbone A, et al. Importance of adequately performed Valsalva maneuver to detect patent foramen ovale during transesophageal echocardiography [J]. J Am Soc Echocardiogr, 2013, 26(11): 1337-1343.
|
19 |
Kumar P, Rusheen J, Tobis JM. A comparison of methods to determine patent foramen ovale size [J]. Catheter Cardiovasc Interv, 2020, 96(6): E621-E629.
|
20 |
Mojadidi MK, Mahmoud AN, Elgendy IY, et al. Transesophageal echocardiography for the detection of patent foramen ovale [J]. J Am Soc Echocardiogr, 2017, 30(9): 933-934.
|
21 |
Ali MA, Hepinstall MJ, Cassidy CS, et al. Agitated blood-saline rather than agitated air-saline for echocardiographic shunt studies [J]. J Am Soc Echocardiogr, 2020, 33(8): 1032-1033.
|
22 |
Freeman JA, Woods TD. Use of saline contrast echo timing to distinguish intracardiac and extracardiac shunts: failure of the 3- to 5-beat rule [J]. Echocardiography, 2008, 25(10): 1127-1130.
|